Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective Mechanism of the Selective Vasopressin V1A Receptor Agonist Selepressin against Endothelial Barrier Dysfunction
Nektarios Barabutis, Маргарита Маринова, Pavel Solopov, et al.
Journal of Pharmacology and Experimental Therapeutics (2020) Vol. 375, Iss. 2, pp. 286-295
Open Access | Times Cited: 9

Showing 9 citing articles:

Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides
Mladena Glavaš, Agata Gitlin‐Domagalska, Dawid Dębowski, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3068-3068
Open Access | Times Cited: 41
Angiotensin ii therapy in refractory septic shock: which patient can benefit most? A narrative review
Irene Coloretti, Andrea Genovese, J. Pedro Teixeira, et al.
Journal of Anesthesia Analgesia and Critical Care (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 8
Endothelial dysfunction: a therapeutic target in bacterial sepsis?
Jean‐Louis Vincent, Can İnce, Peter Pickkers
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 9, pp. 733-748
Closed Access | Times Cited: 25
The HSP90 Inhibitor, AUY-922, Protects and Repairs Human Lung Microvascular Endothelial Cells from Hydrochloric Acid-Induced Endothelial Barrier Dysfunction
Ruben Manuel Luciano Colunga Biancatelli, Pavel Solopov, Betsy Gregory, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1489-1489
Open Access | Times Cited: 20
Alternatives to norepinephrine in septic shock: Which agents and when?
Mathieu Jozwiak
Journal of Intensive Medicine (2022) Vol. 2, Iss. 4, pp. 223-232
Open Access | Times Cited: 12
Management of Sepsis in the First 24 Hours: Bundles of Care and Individualized Approach
Irene Coloretti, M. Tosi, Emanuela Biagioni, et al.
Seminars in Respiratory and Critical Care Medicine (2024) Vol. 45, Iss. 04, pp. 503-509
Closed Access | Times Cited: 2
Vasopressors and Risk of Acute Mesenteric Ischemia: A Worldwide Pharmacovigilance Analysis and Comprehensive Literature Review
Mathieu Jozwiak, Guillaume Géri, Driss Laghlam, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 9
KVX-053, a Protein Tyrosine Phosphatase 4A3 inhibitor, ameliorates SARS‐CoV‐2 Spike protein subunit 1 - induced acute lung injury in mice
Pavel Solopov, Ruben Manuel Luciano Colunga Biancatelli, Tierney Day, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 3, pp. 100022-100022
Open Access | Times Cited: 1
Atosiban-induced acute pulmonary edema: A rare but severe complication of tocolysis
Zuwei Yang, Wei Wu, Yi Yu, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e15829-e15829
Open Access
Page 1

Scroll to top